ROBERT W ADKINS
Electrician at Rr 4, Angleton, TX

License number
Texas 390330
Expiration Date
Jan 23, 2018
Category
Apprentice Electrician
Address
Address
4 Rr 4 BOX 992, Angleton, TX 77515
Phone
(979) 215-4791

Professional information

Robert Adkins Photo 1

Treatment Of Congestive Heart Failure And Autonomic Cardiovascular Drive Disorders

US Patent:
6622041, Sep 16, 2003
Filed:
Aug 21, 2001
Appl. No.:
09/933086
Inventors:
Robert A. Adkins - Angleton TX
Burke T. Barrett - Houston TX
Assignee:
Cyberonics, Inc. - Houston TX
International Classification:
A61N 136
US Classification:
607 9, 607 2
Abstract:
A device for treating patients suffering from congestive heart failure includes an implantable neurostimulator for stimulating the patients vagus nerve at or above the cardiac branch with an electrical pulse waveform at a stimulating rate sufficient to maintain the patients heart beat at a rate well below the patients normal resting heart rate, thereby allowing rest and recovery of the heart muscle, to increase in coronary blood flow, and/or growth of coronary capillaries. A metabolic need sensor detects the patients current physical state and concomitantly supplies a control signal to the neurostimulator to vary the stimulating rate. If the detection indicates a state of rest, the neurostimulator rate reduces the patients heart rate below the patients normal resting rate. If the detection indicates physical exertion, the neurostimulator rate increases the patients heart rate above the normal resting rate.


Robert Adkins Photo 2

Temperature Responsive Controller For Cardiac Pacer

US Patent:
4803987, Feb 14, 1989
Filed:
Jun 11, 1986
Appl. No.:
6/872824
Inventors:
Richard V. Calfee - Houston TX
Robert A. Adkins - Angleton TX
Eckhard U. Alt - Munich, DE
Ross G. Baker - Houston TX
Assignee:
Intermedics, Inc. - Angleton TX
International Classification:
A61N 100, H05G 0000
US Classification:
128419PG
Abstract:
A controller for variably controlling the pacing rate of a cardiac pacer responsive to temperature which includes a logic and control unit, a parameter communication unit, an analog to digital converter and a temperature sensor. The temperature sensor in the right ventricle or atrium communicates a value related to blood temperature through the analog to digital converter to the logic and control unit. The logic and control unit operates under control of the rate algorithm to calculate a pacing rate value related to variations in the blood temperature. The pacing rate value is calculated as the sum of a reference rate, a natural rate response term, and a dynamic rate response term which contributes rate only in response to physical activity. A step rate response is also added to the calculated pacing rate when predetermined criteria related to the blood temperature and calculated pacing rate indicate the onset of physical activity. Under the control of the rate algorithm, the controller also maintains the level and rate of change of the calculated pacing rate within predetermined limits, and prevents the pacing rate from remaining at the maximum rate limit after physical activity has ceased.


Robert Adkins Photo 3

Automatic Activation Of A Neurostimulator Device Using A Detection Algorithm Based On Cardiac Activity

US Patent:
5928272, Jul 27, 1999
Filed:
May 2, 1998
Appl. No.:
9/071856
Inventors:
Robert A. Adkins - Angleton TX
Cormac A. O'Donovan - Clemmons NC
Reese S. Terry - Houston TX
Assignee:
Cyberonics, Inc. - Houston TX
International Classification:
A61N 136
US Classification:
607 45
Abstract:
A device and method of controlling seizures in an epileptic patient, in which the device is implanted in the patient for selective activation to generate an electrical waveform constituting a pre-programmed therapy regimen for application to the patient's vagus nerve to modulate the electrical activity thereof in a manner to inhibit, abort, or reduce the severity and duration of the seizure. The device is activated to generate the waveform upon detecting a time rate of change in the patient's heart rate relative to a predetermined threshold time rate of change which is sufficiently abrupt and of sufficient magnitude to be inconsistent with normal physical activity, as being indicative of an imminent epileptic seizure. Sustained cardiac activity at the highest heart rate detected in the change in heart rate is used as a confirmation of imminent seizure. The electrical waveform is generated a burst of pulses, with a minimum time interval between consecutive pulse bursts selected to avoid overstimulation of the nerve.


Robert Adkins Photo 4

Implantable Device With Circadian Rhythm Adjustment

US Patent:
4922930, May 8, 1990
Filed:
Apr 11, 1989
Appl. No.:
7/336093
Inventors:
Robert A. Adkins - Angleton TX
Ross G. Baker - Houston TX
Assignee:
Intermedics, Inc. - Angleton TX
International Classification:
A61N 100
US Classification:
128419PG
Abstract:
A body function assistance device, capable of analyzing changing but cyclic physiologic needs of a patient and generating a response based on the analysis. A microprocessor in the body function assistance device controls the response of the device to various external events and internal timer events. The microprocessor recognized variations in patterns of recurrent events and adjusts the output of the body function assistance device in response to the detected variations. In a particular embodiment, an implantable cardiac pacer is responsive to a circadian wake-sleep cycle.


Robert Adkins Photo 5

Implantable Device With Circadian Rhythm Adjustment

US Patent:
5143065, Sep 1, 1992
Filed:
Jan 10, 1990
Appl. No.:
7/463233
Inventors:
Robert A. Adkins - Angleton TX
Ross G. Baker - Houston TX
Assignee:
Intermedics, Inc. - Angleton TX
International Classification:
A61N 1362
US Classification:
128419PG
Abstract:
A body function assistance device, capable of analyzing changing but cyclic physiologic needs of a patient and generating a response based on the analysis. A microprocessor in the body function assistance device controls the response of the device to various external events and internal timer events. The microprocessor recognizes variations in patterns of recurrent events and adjusts the output of the body function assistasnce device in response to the detected variations. In a particular embodiment, an implantable cardiac pacer is responsive to a circadian wake-sleep cycle.